Regulatory
Regulatory Policy Analysis
A Tool for Evaluating the Regulatory Framework for Homeopathic Drug Products By Mark Land, AAHP President Today the combination of drug regulations, approval options, cost controls and societal health care…
Read MoreWho Regulates Your Product Labels?
Does the U.S. Food and Drug Administration (FDA) regulate homeopathic product labels? Or does the U.S. Federal Trade Commission (FTC)? Is it both? While most members of the homeopathic industry…
Read MoreA Trump Administration and a Republican-Controlled Congress
An Assessment and Outlook of the Political and Regulatory Climate for 2017 By Pete Evich, AAHP government relations January 1, 2017 The election of Donald Trump and a Republican-controlled Congress…
Read MoreAAHP Encourages Clear and Open Communication on Teething Medicines Tragedies
In the interest of public safety, the American Association of Homeopathic Pharmacists (AAHP) encourages the U.S. Food and Drug Administration to provide clear and open communication on their ongoing investigation…
Read MoreU.S. Senator Bob Casey to Attend Event Sponsored by Keystone State-Based AAHP Members
Executives from AAHP member companies that reside in Pennsylvania will be hosting a political event on Tuesday, Oct. 25 for one of their home state senators, Sen. Bob Casey (D).…
Read MoreFTC Holds Workshop on Consumer Disclaimers
The complexity of developing and delivering product disclosures to consumers was the subject of a day-long workshop hosted by the Federal Trade Commission (FTC) on Sept. 15 in Washington, DC.…
Read MoreUS FDA Establishment Inspections: Outcomes for Labelers for Homeopathic Drugs
By Mark Land, AAHP President, June 2016 Abstract Labelers of homeopathic drugs are a subset of drug manufacturing establishments located within the United States and internationally. Homeopathic drugs are regulated…
Read MoreUnderstanding OTC Monograph Reform: Where Do We Stand Now?
By J.P. Borneman, Ph.D. and Alvin J. Lorman, J.D. The FDA’s Over-the-Counter Drug Review (OTC Review) has always been important to homeopathy, despite the fact that homeopathic drugs are not…
Read MoreFDA Guidance for Industry – Request for Quality Metrics
By Mark Land, AAHP President FDA published its draft guidance, Request for Quality Metrics; Guidance for Industry1. Advancing the background on the initiative in general, this draft reveals 10 mandatory…
Read MoreConsideration of Homeopathic Medicine as a Vaccine Alternative
Milwaukie, Ore., Autumn 2015—As the public debate on vaccinations rises, more healthcare providers and parents alike seek information. The American Association Homeopathic Pharmacists (AAHP) reminds manufacturers and marketers that the promotion…
Read More